Zymeworks Enters Major Collaboration with Roche for ZW209
Zymeworks has signed a collaboration agreement with Roche, granting exclusive rights to develop ZW209, a promising cancer treatment, with significant financial incentives.
In Focus
Transocean announces merger with Valaris, pending approvals
Transocean Ltd. reveals a merger with Valaris Limited, a strategic move in the drilling oil and gas wells sector, pending shareholder approvals.
Across the Market
Latest Filings
More Deals News
Auddia Inc. Enters Merger Agreement and Amends Bridge Funding
Auddia Inc. announces a merger with McCarthy Finney and Thramann Holdings, along with amendments to bridge funding agreements to support the merger.
Tenon Medical Enters Agreement to Increase Share Offerings
Tenon Medical, Inc. has entered a new agreement to increase its share offerings, enhancing its financial flexibility and market presence.
ContextLogic amends stock purchase agreement, plans rights offering
ContextLogic Holdings Inc. has amended its stock purchase agreement, increasing share rollover to $7 million and planning a rights offering.
Net Power extends EPC agreement deadline with Saulsbury Industries
Net Power Inc. extends deadline for EPC agreement with Saulsbury Industries, impacting project timelines and financial obligations.
Globa Terra Acquisition Corp Faces Nasdaq Delisting Risk
Globa Terra Acquisition Corp risks delisting from Nasdaq after failing to complete a business combination, plans to appeal decision.
Trinity Industries Secures $349.8 Million Term Loan for Railcars
Trinity Industries has secured a $349.8 million term loan to acquire railcars, enhancing its position in the railroad equipment industry.
Varex Imaging Advances Merger with Teledyne Amid Lawsuits
Varex Imaging Corp is advancing its merger with Teledyne Technologies despite shareholder lawsuits challenging the deal. A special meeting is set for October 28.
Artificial Intelligence Technology Solutions Secures New Orders
AITX announces new orders for its AI-driven security products, signaling growth and increased acceptance in the prepackaged software industry.
Arbutus Biopharma Gains FDA Clearance for AB-101 Trials
Arbutus Biopharma announced FDA lifted clinical hold on AB-101, its oral PD-L1 inhibitor, allowing further trials. This could impact the hepatitis B treatment landscape.
K&F Growth Acquisition Corp. II Enters New Agreement with David's Bridal
K&F Growth Acquisition Corp. II announces a new agreement with David's Bridal, marking a potential business combination in the wedding industry.
Sagimet Biosciences updates investors on clinical progress
Sagimet Biosciences provides an investor update on clinical developments and financial health, focusing on key drug candidates targeting acne and metabolic diseases.
Newbury Street II Acquisition Corp Enters Merger Agreement
Newbury Street II Acquisition Corp announces merger with Fort Robotics, marking a pivotal moment in its growth strategy within the electrical industrial apparatus sector.
Unusual Machines secures $16.9M order from Powerus Corporation
Unusual Machines, Inc. announces a $16.9 million purchase order from Powerus for drone components, enhancing its position in the growing market.
Farmers & Merchants Bancorp Releases Investor Presentation
Farmers & Merchants Bancorp shares updates on financial position and operations through an investor presentation, signaling transparency in the banking sector.
TruGolf regains Nasdaq compliance after Polymath acquisition
TruGolf Holdings, Inc. regains compliance with Nasdaq's equity requirement after acquiring Polymath Research Inc., impacting the sporting goods industry.
Full House Resorts plans permanent casino, seeks refinancing
Full House Resorts Inc. announces plans for a permanent casino in Waukegan, Illinois, while negotiating refinancing options for existing debt.
Integrated Rail & Resources Secures $944K in Preferred Stock Deal
Integrated Rail & Resources Inc. announces a $944,400 financing deal with Huntington Oil & Gas III, LLC to enhance operational capabilities.
GSK secures FDA approval for Ionis' HIBSAGO™ for hepatitis B
Ionis Pharmaceuticals' partner GSK receives FDA approval for HIBSAGO™, a groundbreaking treatment for chronic hepatitis B, enhancing patient care.
Navient Corp Announces Tax-Free Merger to Form New Holding Company
Navient Corp plans a tax-free merger to form a new holding company, enhancing operations and shareholder value without requiring a stockholder vote.
Valor Energy closes private placement, issues new warrants
Valor Energy Inc. closes a private placement, issuing warrants to investors, potentially strengthening its financial position amid compliance challenges.
Texas Ventures Acquisition III Corp extends business combination deadline
Texas Ventures Acquisition III Corp extends its deadline for a business combination to July 2027, reflecting challenges in the blank check company sector.
PUBLIC CO MANAGEMENT CORP Establishes New Series of Preferred Stock
PUBLIC CO MANAGEMENT CORP has filed to establish three new series of Preferred Stock, altering its capital structure and voting dynamics.
Lifecore Biomedical sets date for stockholder merger vote
Lifecore Biomedical has scheduled a special meeting for stockholders to vote on a merger agreement with Lifecore Inc., impacting the pharmaceutical industry.
Conexeu Sciences reports $5 million in unregistered stock sales
Conexeu Sciences Inc. announces nearly $5 million in unregistered stock sales to enhance working capital and support corporate initiatives.